Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties <i>via</i> PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Huijuan,Liu ^[1] ; Honglian,Tao ^[2] ; Hongqi,Wang ^[3] ; Yuyan,Yang ^[1] ; Ru,Yang ^[2] ; Xintong,Dai ^[1] ; Xiujuan,Ding ^[2] ; Haidong,Wu ^[1] ; Shuang,Chen ^[2] ; Tao,Sun ^[1]

作者单位： State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China. ^[1] Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs, Tianjin International Joint Academy of Biomedicine, Tianjin, China. ^[2] Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin Third Central Hospital, Tianjin, China. ^[3] Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin Institute of Digestive Disease, Tianjin, China. ^[4]

关键词 doxycycline epithelial–mesenchymal transformation focal adhesion kinase pancreatic cancer stem cells protease activation receptor 1

DOI 10.3389/fonc.2022.830506

PMID 35280769

发布时间 2022-03-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2022年12卷

830506页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties <i>via</i> PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties <i>via</i> PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除